Page last updated: 2024-11-06

corticosterone and Psychoses, Drug

corticosterone has been researched along with Psychoses, Drug in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reynolds, AR1
Saunders, MA1
Brewton, HW1
Winchester, SR1
Elgumati, IS1
Prendergast, MA1
Carey, RJ1
Pinheiro-Carrera, M1
Dai, H1
Tomaz, C1
Huston, JP1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PT150 (Formerly ORG34517) as a Potential Treatment for Alcohol Dependence-Alcohol Interaction Study[NCT03548714]Phase 110 participants (Actual)Interventional2018-09-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for corticosterone and Psychoses, Drug

ArticleYear
Acute oral administration of the novel, competitive and selective glucocorticoid receptor antagonist ORG 34517 reduces the severity of ethanol withdrawal and related hypothalamic-pituitary-adrenal axis activation.
    Drug and alcohol dependence, 2015, Sep-01, Volume: 154

    Topics: Administration, Oral; Alcohol Drinking; Alcoholism; Animals; Benzodioxoles; Corticosterone; Ethanol;

2015
L-DOPA and psychosis: evidence for L-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone.
    Biological psychiatry, 1995, Nov-15, Volume: 38, Issue:10

    Topics: Animals; Antiparkinson Agents; Corpus Striatum; Corticosterone; Dopamine; Homovanillic Acid; Levodop

1995